Ethic Inc’s Core Laboratories CLB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-10,588
Closed -$159K 1231
2025
Q1
$159K Sell
10,588
-3,863
-27% -$64.7K ﹤0.01% 1089
2024
Q4
$250K Buy
14,451
+4,389
+44% +$84.7K 0.01% 985
2024
Q3
$172K Sell
10,062
-4,084
-29% -$82K ﹤0.01% 1017
2024
Q2
$287K Buy
14,146
+4,084
+41% +$72.3K 0.01% 923
2024
Q1
$172K Buy
+10,062
New +$158K ﹤0.01% 1016

Other funds holding CLB

Ethic Inc's CLB Position: Q2 2025 in Review

Ethic Inc sold out of Core Laboratories (CLB) in Q2 2025, closing a stake of 10,588 shares — an estimated $159K sold.

Ethic Inc first reported a position in CLB in Q1 2024 and held it in 5 quarters. The position peaked at $287K in Q2 2024. 191 funds tracked by Wall St. Rank hold CLB as of Q2 2025.

  • Ethic Inc reported no remaining Core Laboratories position as of Q2 2025 after selling out during the quarter.
  • Ethic Inc sold 10,588 Core Laboratories shares in Q2 2025, an estimated $159K.
  • Ethic Inc first reported a position in Core Laboratories in Q1 2024 and held it in 5 quarters.
  • Ethic Inc's Core Laboratories position peaked at $287K in Q2 2024.
  • 191 funds tracked by Wall St. Rank held Core Laboratories as of Q2 2025.

Based on Ethic Inc's 13F filing for Q2 2025, filed 30 Jul 2025.